EMPLOYMENT AGREEMENTEmployment Agreement • August 9th, 2016 • Intercept Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS EMPLOYMENT AGREEMENT (the “Agreement”), made effective as of May 3, 2016, is entered into by Intercept Pharmaceuticals, Inc. (the “Company”) and Sandip S. Kapadia (“Executive”).
AND NON-SOLICITATION AGREEMENTInvention, Non-Disclosure, Non-Competition and Non-Solicitation Agreement • August 9th, 2016 • Intercept Pharmaceuticals Inc • Pharmaceutical preparations • New York
This Invention, Non-Disclosure, Non-Competition and Non-Solicitation Agreement is made by and between Intercept Pharmaceuticals, Inc. (the "Company") and Sandip Kapadia (the "Employee").
Ms. Barbara Duncan Re: Amendment No. 1 to Transition Agreement Dear Barbara:Transition Agreement • August 9th, 2016 • Intercept Pharmaceuticals Inc • Pharmaceutical preparations • New York
This letter serves as an amendment (the “Amendment”) to the letter agreement entered into by and between yourself and Intercept Pharmaceuticals, Inc. (“Intercept”) on February 16, 2016 (the “Original Transition Agreement”). This Amendment shall become effective upon full execution below and shall modify the Transition Agreement with respect to those different and additional terms as set forth below (the Original Transition Agreement, as amended by this Amendment, shall be referred as the “Transition Agreement”). Except as set forth herein, the Original Transition Agreement shall remain unchanged. Initially capitalized terms used herein but not defined shall have the meaning set forth in the Original Transition Agreement.
